Opinion|Videos|December 23, 2024

Case 1: A 68-Year-Old Man with Bone-Predominant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Author(s)Jose De La Cerda III, MD, MPH

Episodes in this series

EP. 1 Bone Predominant mCRPC Patient Case

EP. 1 Bone Predominant mCRPC Patient Case

EP. 2 Case 1: A 68-Year-Old Man with Bone-Predominant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

EP. 2 Case 1: A 68-Year-Old Man with Bone-Predominant Metastatic Castration-Resistant Prostate Cancer (mCRPC)

EP. 3 Abiraterone Acetate Versions for Treatment of mCRPC

EP. 3 Abiraterone Acetate Versions for Treatment of mCRPC

EP. 4 Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

EP. 4 Patient Selection Criteria for Different Versions of Abiraterone Acetate in mCRPC

EP. 5 Assessing Treatment Efficacy: Communication with Patients and Caregivers

EP. 5 Assessing Treatment Efficacy: Communication with Patients and Caregivers

EP. 6 Patient with mCRPC and Hepatic Disease

EP. 6 Patient with mCRPC and Hepatic Disease

EP. 7 Treatment and Co-Management of mCRPC Patients with Aggressive Disease

EP. 7 Treatment and Co-Management of mCRPC Patients with Aggressive Disease

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Related Content

Referral Pathways and Unmet Needs in Perioperative MIBC Care

ByJoshua J. Meeks, MD, PhD

September 4th 2026

MIBC Treatment Timeline and Skin Toxicity: What Urologists Should Know

ByJoshua J. Meeks, MD, PhD

September 4th 2026

What the Efficacy Data from KEYNOTE-B15/EV-304 Revealed

ByJoshua J. Meeks, MD, PhD

September 4th 2026

FDA Expands MIBC Approval: What Changed for Platinum-Eligible Patients

ByJoshua J. Meeks, MD, PhD

September 4th 2026

Rectal Spacer Evidence: Acute Toxicity, Durability, and Safety

ByAurelie Garant, MD,Daniel Welchons, MD

September 4th 2026

Latest CME

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Trending on Urology Times

Alternative BCG strains may help address ongoing supply challenges in NMIBC

Doublet or triplet? Urologists weighs in on mCSPC options

Pearls & Perspectives: Sexual Health and Intimacy in Midlife, With Karen Bigman, MBA

The role of diet and lifestyle in prostate cancer care, with Lorelei A. Mucci, ScD, MPH

Phase 3 trial of padeliporfin VTP completes treatment in LG-UTUC